S+N acquires the Integra LifeScience extremity business for $240M (2.6X sales)

With this move, effectively S+N has dropped out as a suitor to outbid Stryker for Wright Medical. Read more - Everything you need to know about the Stryker-Wright acquisition

Integra LifeSciences Announces Definitive Agreement To Divest Its Extremity Orthopedics Business To Smith+Nephew For $240 Million (press release)
 Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has entered into a definitive agreement to sell its Extremity Orthopedics business to Smith+Nephew (LSE:SN, NYSE:SNN) for $240 million in cash...